City

Condition

HRAS Mutations or Peripheral T Cell Lymphoma (PTCL) (1)

Overall Status

Available (1)

Sign in for free

Phase

Sponsor

Kura Oncology, Inc. (1)

Collaborator

Intervention

tipifarnib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Expanded Access (1)

hras mutations or peripheral t cell lymphoma (ptcl)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

HRAS Mutations or Peripheral T Cell Lymphoma (PTCL) Trial (Tipifarnib)

Available

HRAS Mutations or Peripheral T Cell Lymphoma (PTCL)

Tipifarnib

(no location specified)

Jun 7, 2022